Human iPSC-derived neurons reveal early developmental alteration of neurite outgrowth in the late-occurring neurodegenerative Wolfram syndrome.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
04 11 2021
Historique:
received: 20 05 2021
accepted: 30 09 2021
pubmed: 27 10 2021
medline: 23 11 2021
entrez: 26 10 2021
Statut: ppublish

Résumé

Recent studies indicate that neurodegenerative processes that appear during childhood and adolescence in individuals with Wolfram syndrome (WS) occur in addition to early brain development alteration, which is clinically silent. Underlying pathological mechanisms are still unknown. We have used induced pluripotent stem cell-derived neural cells from individuals affected by WS in order to reveal their phenotypic and molecular correlates. We have observed that a subpopulation of Wolfram neurons displayed aberrant neurite outgrowth associated with altered expression of axon guidance genes. Selective inhibition of the ATF6α arm of the unfolded protein response prevented the altered phenotype, although acute endoplasmic reticulum stress response-which is activated in late Wolfram degenerative processes-was not detected. Among the drugs currently tried in individuals with WS, valproic acid was the one that prevented the pathological phenotypes. These results suggest that early defects in axon guidance may contribute to the loss of neurons in individuals with WS.

Identifiants

pubmed: 34699745
pii: S0002-9297(21)00355-4
doi: 10.1016/j.ajhg.2021.10.001
pmc: PMC8595949
pii:
doi:

Substances chimiques

Valproic Acid 614OI1Z5WI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2171-2185

Informations de copyright

Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

BMC Genomics. 2015 Dec 16;16:1069
pubmed: 26673413
Int J Biol Sci. 2015 May 19;11(7):752-61
pubmed: 26078717
Science. 2009 May 8;324(5928):797-801
pubmed: 19325077
Neurobiol Aging. 2015 Jan;36 Suppl 1:S151-8
pubmed: 25264344
Orphanet J Rare Dis. 2019 Dec 3;14(1):279
pubmed: 31796109
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a001784
pubmed: 20300212
Neurosci Res. 2019 Feb;139:69-78
pubmed: 30261202
J Neurosci. 2018 May 16;38(20):4655-4665
pubmed: 29712788
Am J Dis Child. 1977 Dec;131(12):1382-5
pubmed: 930889
Curr Opin Neurobiol. 2013 Dec;23(6):974-82
pubmed: 23973157
Stem Cells Dev. 2018 Jul 15;27(14):968-975
pubmed: 29415619
EBioMedicine. 2016 Jul;9:293-305
pubmed: 27333044
Nat Biotechnol. 2009 Mar;27(3):275-80
pubmed: 19252484
J Transl Med. 2019 Jul 23;17(1):238
pubmed: 31337416
J Clin Invest. 2010 Mar;120(3):744-55
pubmed: 20160352
Int J Mol Sci. 2017 Feb 08;18(2):
pubmed: 28208696
Regen Med. 2015;10(2):193-209
pubmed: 25485637
Br J Pharmacol. 2015 Aug;172(16):4200-15
pubmed: 26040297
J Neurosci Res. 2010 Nov 1;88(14):3189-97
pubmed: 20645406
Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
PLoS Biol. 2016 Jul 19;14(7):e1002511
pubmed: 27434582
Ann Neurol. 1996 Mar;39(3):352-60
pubmed: 8602754
Acta Neuropathol. 1999 Sep;98(3):304-8
pubmed: 10483789
Sci Rep. 2019 Apr 12;9(1):6010
pubmed: 30979932
Sci Rep. 2019 Oct 31;9(1):15742
pubmed: 31673100
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Trends Pharmacol Sci. 2019 Oct;40(10):711-714
pubmed: 31420094
J Biol Chem. 2005 Nov 25;280(47):39609-15
pubmed: 16195229
Hum Mol Genet. 2013 Jan 15;22(2):203-17
pubmed: 23035048
PLoS One. 2012;7(7):e40604
pubmed: 22792385
Hum Mol Genet. 2001 Mar 1;10(5):477-84
pubmed: 11181571
Lancet. 1995 Dec 2;346(8988):1458-63
pubmed: 7490992
Lancet Neurol. 2015 May;14(5):532-46
pubmed: 25769423
Nat Chem Biol. 2019 Aug;15(8):764-775
pubmed: 31320759
Sci Rep. 2017 Aug 31;7(1):10220
pubmed: 28860598
Diabetologia. 2018 Oct;61(10):2189-2201
pubmed: 30054673
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):E5292-301
pubmed: 25422446
J Neurosci Res. 2013 Nov;91(11):1408-18
pubmed: 23963795
J Neurochem. 2020 Apr;153(1):10-32
pubmed: 31630412
Ann Neurol. 2011 Mar;69(3):501-8
pubmed: 21446023
Diabetes. 2014 Mar;63(3):844-6
pubmed: 24556864
PLoS Genet. 2018 Jan 22;14(1):e1007196
pubmed: 29357349
Nat Rev Neurosci. 2005 Aug;6(8):615-25
pubmed: 16062170
Elife. 2016 Jul 20;5:
pubmed: 27435962
Diabetes Care. 2011 Jul;34(7):1503-10
pubmed: 21602428
Nat Commun. 2015 Jun 03;6:7246
pubmed: 26037503
Front Physiol. 2019 Mar 13;10:172
pubmed: 30930784
Diabetes. 2014 Mar;63(3):923-33
pubmed: 24227685
F1000Res. 2017 Jan 25;6:78
pubmed: 28163913
Neurosci Res. 2009 Sep;65(1):35-43
pubmed: 19463867
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Transl Psychiatry. 2013 Aug 20;3:e294
pubmed: 23962924
Development. 2012 Apr;139(7):1247-57
pubmed: 22357933
Trends Neurosci. 2009 Mar;32(3):142-9
pubmed: 19162339
Sci Rep. 2016 Feb 18;6:21167
pubmed: 26888576

Auteurs

Sandra Pourtoy-Brasselet (S)

CECS/AFM, I-STEM, Corbeil-Essonnes 91100, France.

Axel Sciauvaud (A)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France.

Maria-Gabriela Boza-Moran (MG)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France.

Michel Cailleret (M)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France.

Margot Jarrige (M)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France; CECS/AFM, I-STEM, Corbeil-Essonnes 91100, France.

Hélène Polvèche (H)

CECS/AFM, I-STEM, Corbeil-Essonnes 91100, France.

Jérôme Polentes (J)

CECS/AFM, I-STEM, Corbeil-Essonnes 91100, France.

Eric Chevet (E)

INSERM U1242, Université Rennes 1, Rennes 35000, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes 35000, France.

Cécile Martinat (C)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France.

Marc Peschanski (M)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France; CECS/AFM, I-STEM, Corbeil-Essonnes 91100, France.

Laetitia Aubry (L)

INSERM UMR 861, I-STEM, AFM, Corbeil-Essonnes 91100, France; Université Paris-Saclay, INSERM, Univ Evry, Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques, Corbeil-Essonnes 91100, France. Electronic address: laubry@istem.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH